Cristin-resultat-ID: 1811253
Sist endret: 18. mai 2020, 14:20
Resultat
Rapport
2020

Handelen med medisinske varer og Covid-19

Bidragsytere:
  • Arne Melchior

Utgiver/serie

Utgiver

NUPI

Serie

NUPI Covid-19 Brief

Om resultatet

Rapport
Publiseringsår: 2020
Volum: 2020
Hefte: 6
Antall sider: 7
Revidert utgave
Open Access

Klassifisering

Vitenskapsdisipliner

Internasjonal politikk

Emneord

Internasjonal økonomi • Europa • Globalisering • Humanitære spørsmål

Fagfelt (NPI)

Fagfelt: Statsvitenskap
- Fagområde: Samfunnsvitenskap

Beskrivelse Beskrivelse

Tittel

Handelen med medisinske varer og Covid-19

Sammendrag

The Covid-19 pandemy has exposed vulnerability for pharmaceuticals and medical goods. Does globalisation create more or less vulnerability? - The majority of countries import all their drugs and only eight countries are net exporters. - Exports are dominated by Western Europa, with China and India some way down the list. - Globalisation has spread the risk for medical goods by an increased number of suppliers and less export concentration. A main driver is increased export from small European countries. - At a more detailed level of goods, the picture is more mixed, with growing concentration in some cases. - Export restrictions contribute to market collapse and higher prices, that particularly hit poor countries that import all their needs. - For Norway, European integration is important for medical contingency planning.

Bidragsytere

Arne Melchior

  • Tilknyttet:
    Forfatter
    ved Russland, Eurasia og internasjonal handel ved Norsk Utenrikspolitisk Institutt
1 - 1 av 1